Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Sep 21, 2005 5:37pm
257 Views
Post# 9585434

the silence is deafening....

the silence is deafening.... Really disappointing silence from the company over the last few months.... How long have we been hearing about all of these imminent "unexpected" catalysts. How many times do we have to be content with hearing, " there's lots going on that we cant talk about " !!??? or "everyone is busy" I think the company is confusing silencing all of the loose lips with fundamental promotion of the company initiatives... Think about this, what was the last pc of truly and undeniably promotable news on this stock ? THE ARC Partnership ?? Its no wonder the one and two year charts looks like the the Peak to Creek run at Whistler Mountain We expect analysts to write about the company, we expect the press to write about the company, we expect ROB TV to run pcs on the company, we expect institutions to take an interest in this company.... WHAT TANGIBLE NEWS OR DEVELOPMENT HAVE WE GIVEN THEM IN THE LAST 6 months, one year ?? Animal diagnostics ? that was weak... Tunisia... nope 1402... nope... delays...wishy-washy promises and further delays on PhaseII.. We were told A YEAR AGO that the extended Phase ONE cohorts would be completed by APRIL of this year.... NOTHING... still nothing definitive on when or if Phase II will go.. What happened to all the alleged discussions with Amgen or other major pharma allegedly interested in this "blockbuster" drug... ?? what happended to licensing out the drug, joint development... royalty streams ?? What happened to further Cascade / Frac licensing agreements...?? What happened to partial implementation of Cascade at existing COHN FRAC plants with one or more of the major players ?? What happened to all of the Ligand sales and drug development platforms with all of the fabulous partners we have ?? FINALLY.... IS there NOTHING promotable about the course of the endogenous test... ? Are we not on the verge of making an absolutely HUGE MEDICAL breakthrough....?? The ability to safely filter out 99.9% of BSE Prions in BLOOD ?? Shouldnt we be talking to someone about that ?? Shouldnt the media, the market the industry be ALL OVER THIS STORY ?? ARENT we on the verge of being the FIRST COMPANY ever to CO-DEVELOP and MARKET a PRODUCT capable of adding a HUGE margin of safety to the WORLD BLOOD SUPPLY ??? ARENT we on the verge of implementing this technology in ENGLAND, FRANCE, GERMANY etc to effectively render their blood supply SAFE from MAD COW DISEASE....!!??? ISNT THAT SOMEWHAT PROMOTEABLE ??? THE SILENCE IS DEAFENING AND WE PRINT A NEW 3 year low... unbelievable... PIERRE / NICOLE / VINCENT / KYM / ANDREW.... PLEASE
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse